Ahead of next week's federal budget, the Albanese government said that a re-elected Labor government would lower the price of ...
4d
Axios on MSNA blueprint for Trump to address drug pricesThe America First Policy Institute — the think tank founded and staffed by Trump officials to advance his vision for the ...
Third-party companies known as pharmacy benefit managers, which administer prescription drug benefits for health insurance ...
Bulgaria wants pharmaceutical policies to remain within the member states’ competence, a position which risks undermining the ...
The S&P 500 edged 0.2% higher on Tuesday, March 25, despite a report showing that consumer confidence fell to its lowest ...
5d
India Today on MSNMounjaro, popular weight-loss drug, launched in India. Here's how much it costsPopular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...
4d
India Today on MSNMounjaro enters India as weight-loss drug, but doctors warn against misuseWhile experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.
You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of ...
The state's insurance regulator has been seeking such information as patient names, dates of birth and prescription details.
Me has tested more than 15m people’s genetic makeup using post-in saliva kits – including more than 250,000 in the UK - ...
Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results